rabeprazole has been researched along with Neurodegenerative Diseases in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Usman, H | 1 |
| Tan, Z | 1 |
| Gul, M | 1 |
| Rashid, S | 1 |
| Ali, T | 1 |
| Shah, FA | 1 |
| Li, S | 1 |
| Li, JB | 1 |
1 other study available for rabeprazole and Neurodegenerative Diseases
| Article | Year |
|---|---|
Identification of novel and potential PPARĪ³ stimulators as repurposed drugs for MCAO associated brain degeneration.
Topics: Animals; Brain; Brain Ischemia; Ethambutol; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mol | 2022 |